Melanoma epidemiology, biology and prognosis.
作者信息
Ali Z, Yousaf N, Larkin J
机构信息
Royal Marsden Hospital, London, UK.
出版信息
EJC Suppl. 2013 Sep;11(2):81-91. doi: 10.1016/j.ejcsup.2013.07.012.
Abstract
摘要
相似文献
1
Melanoma epidemiology, biology and prognosis.黑色素瘤的流行病学、生物学及预后
EJC Suppl. 2013 Sep;11(2):81-91. doi: 10.1016/j.ejcsup.2013.07.012.
2
Mucosal Melanoma: Epidemiology, Biology and Treatment.黏膜黑色素瘤：流行病学、生物学及治疗
Cancer Treat Res. 2016;167:295-320. doi: 10.1007/978-3-319-22539-5_13.
3
Advances in melanoma: epidemiology, diagnosis, and prognosis.黑色素瘤的进展：流行病学、诊断与预后
Front Med (Lausanne). 2023 Nov 22;10:1268479. doi: 10.3389/fmed.2023.1268479. eCollection 2023.
4
A Review of Epidemiology and Cancer Biology of Malignant Melanoma.恶性黑色素瘤的流行病学与癌症生物学综述
Cureus. 2021 May 18;13(5):e15087. doi: 10.7759/cureus.15087.
5
Genetic epidemiology of melanoma.黑色素瘤的遗传流行病学
Eur J Dermatol. 2016 Aug 1;26(4):335-9. doi: 10.1684/ejd.2016.2787.
6
Epidemiology and treatment of melanoma in elderly patients.老年患者黑色素瘤的流行病学和治疗。
Nat Rev Clin Oncol. 2010 Mar;7(3):148-52. doi: 10.1038/nrclinonc.2010.1. Epub 2010 Feb 9.
7
Epidemiology and prognosis of anorectal melanoma.肛管直肠黑色素瘤的流行病学与预后
Gastroenterology. 1993 Jan;104(1):174-8. doi: 10.1016/0016-5085(93)90849-8.
8
Melanoma of the Lower Limbs and Hips: A Surveillance, Epidemiology, and End Results Analysis of Epidemiology and Survival 2000-2019.下肢和臀部黑色素瘤：2000-2019 年的监测、流行病学和结局分析的流行病学和生存情况。
Anticancer Res. 2023 Sep;43(9):4105-4113. doi: 10.21873/anticanres.16600.
9
Demographic and socioeconomic predictors of melanoma prognosis in the United States.美国黑色素瘤预后的人口统计学和社会经济预测因素。
J Health Care Poor Underserved. 2009 Feb;20(1):227-45. doi: 10.1353/hpu.0.0113.
10
Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology.肢端黑色素瘤足部病变。第一部分：流行病学、病因学和分子病理学。
Clin Exp Dermatol. 2017 Dec;42(8):845-848. doi: 10.1111/ced.13243. Epub 2017 Sep 22.
引用本文的文献
1
Salidroside inhibits melanin synthesis and melanoma growth via mTOR and PI3K/Akt pathways.红景天苷通过mTOR和PI3K/Akt信号通路抑制黑色素合成及黑色素瘤生长。
Front Oncol. 2025 Jul 10;15:1583580. doi: 10.3389/fonc.2025.1583580. eCollection 2025.
2
Barriers to Skin Cancer Diagnosis and Treatment in Low- and Middle-Income Countries and Solutions: A Literature Review.低收入和中等收入国家皮肤癌诊断与治疗的障碍及解决方案：文献综述
Public Health Chall. 2025 Mar 11;4(1):e70042. doi: 10.1002/puh2.70042. eCollection 2025 Mar.
3
Evaluation of skin cancer prevention properties of probiotics.益生菌预防皮肤癌特性的评估。
Genes Nutr. 2025 May 23;20(1):12. doi: 10.1186/s12263-025-00770-z.
4
Insights into Liposomal and Gel-Based Formulations for Dermatological Treatments.皮肤治疗用脂质体和凝胶制剂的见解
Gels. 2025 Mar 26;11(4):245. doi: 10.3390/gels11040245.
5
Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma.神经嵴相关基因FOXD1通过调节黑色素瘤中的髓源性抑制细胞诱导免疫抑制微环境。
J Immunother Cancer. 2025 Apr 9;13(4):e010352. doi: 10.1136/jitc-2024-010352.
6
Nanostructured Formulations for a Local Treatment of Cancer: A Mini Review About Challenges and Possibilities.用于癌症局部治疗的纳米结构制剂：关于挑战与可能性的综述
Pharmaceutics. 2025 Feb 6;17(2):205. doi: 10.3390/pharmaceutics17020205.
7
Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation.用于治疗色素沉着过度的小分子酪氨酸酶抑制剂
Molecules. 2025 Feb 8;30(4):788. doi: 10.3390/molecules30040788.
8
The potential impact of ACOG guideline changes on genital melanoma detection rates in females: a retrospective cross-sectional analysis and implications for clinical practice.美国妇产科医师学会（ACOG）指南变更对女性生殖器黑色素瘤检出率的潜在影响：一项回顾性横断面分析及对临床实践的启示
Arch Dermatol Res. 2025 Feb 19;317(1):438. doi: 10.1007/s00403-025-03960-2.
9
Adjuvant Proton Beam Radiation Therapy for Sinonasal Mucosal Melanoma.辅助性质子束放射治疗鼻窦黏膜黑色素瘤
Cancer Rep (Hoboken). 2025 Feb;8(2):e70111. doi: 10.1002/cnr2.70111.
10
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects.低剂量辐射协同增强转移性黑色素瘤免疫治疗疗效：当前见解与展望
J Exp Clin Cancer Res. 2025 Jan 30;44(1):31. doi: 10.1186/s13046-025-03281-2.
本文引用的文献
1
The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis.BRAF 突变在结直肠癌和黑色素瘤中的预后价值：系统评价和荟萃分析。
PLoS One. 2012;7(10):e47054. doi: 10.1371/journal.pone.0047054. Epub 2012 Oct 9.
2
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.BAP1 癌症综合征：恶性间皮瘤、葡萄膜和皮肤黑色素瘤以及 MBAITs。
J Transl Med. 2012 Aug 30;10:179. doi: 10.1186/1479-5876-10-179.
3
Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.BRAF(V600) 突变在转移性淋巴结切除术后黑色素瘤患者中的预后价值。
Ann Surg Oncol. 2012 Dec;19(13):4314-21. doi: 10.1245/s10434-012-2457-5. Epub 2012 Jul 7.
4
Melanoma incidence and mortality in Europe: new estimates, persistent disparities.欧洲的黑色素瘤发病率和死亡率：新的估计数，持续存在的差距。
Br J Dermatol. 2012 Nov;167(5):1124-30. doi: 10.1111/j.1365-2133.2012.11125.x. Epub 2012 Sep 7.
5
Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.联合使用小分子 MEK 和 PI3K 抑制剂可增强依赖突变 GNAQ 和 GNA11 的葡萄膜黑色素瘤细胞死亡。
Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
6
Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways.蛋白激酶 C 抑制剂 AEB071 通过影响 PKC/Erk1/2 和 PKC/NF-κB 通路靶向携带 GNAQ 突变的眼黑素瘤。
Mol Cancer Ther. 2012 Sep;11(9):1905-14. doi: 10.1158/1535-7163.MCT-12-0121. Epub 2012 May 31.
7
Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials.女性 I 期/II 期皮肤黑色素瘤患者的预后更佳：四项欧洲癌症研究与治疗组织（EORTC）三期临床试验的汇总分析。
J Clin Oncol. 2012 Jun 20;30(18):2240-7. doi: 10.1200/JCO.2011.38.0584. Epub 2012 Apr 30.
8
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.胚系 BAP1 失活与转移性眼黑色素瘤和皮肤眼黑色素瘤家族优先相关。
PLoS One. 2012;7(4):e35295. doi: 10.1371/journal.pone.0035295. Epub 2012 Apr 24.
9
Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.澳大利亚昆士兰州人群中诊断为薄型黑色素瘤患者的 20 年生存率。
J Clin Oncol. 2012 May 1;30(13):1462-7. doi: 10.1200/JCO.2011.38.8561. Epub 2012 Mar 12.
10
Cancer statistics, 2012.癌症统计数据，2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
Zotero 插件